INTRODUCTION
The aggressive brain tumor glioblastoma multiforme (GBM) accounts for about 50% of all glial tumors in adults, with a median survival of 12-15 months. 1, 2 GBMs are heterogeneous, invasive and vascularized with a strong hypoxic/necrotic component, making them refractory to radio-and chemotherapy. 3 Besides genetic alterations that contribute to the aggressiveness of GBM, 4, 5 it is evident that not all tumor cells are equally tumorigenic. Proliferative and undifferentiated tumor cell subpopulations, described as glioma-initiating cells (GICs), can contribute to cancer initiation, propagation and relapse after therapy. 2, 3 Similar to adult stem cells that sustain tissue homeostasis, GICs can sustain aberrant tumor growth. 6 A correlation found between tumor subtypes and stage of differentiation suggested that glioblastoma aggressiveness might be governed by processes that regulate adult brain-stem cell fate. 7 Cytokines are critical regulators of adult brain-stem cell, and GIC differentiation and renewal. 8 Transforming growth factor b (TGFb) and its related bone morphogenetic proteins (BMPs) signal via serine/threonine kinase receptors, intracellular Smad proteins and kinase effector pathways that regulate gene expression. 9 TGFb helps maintaining human GICs by inducing expression of platelet-derived growth factor B, leukemia inhibitory factor (LIF) and the transcription factor Sox4 that contribute to GIC proliferation and survival. [10] [11] [12] TGFb type I receptor kinase inhibitors 13 can deplete a pool of primary human GICs, 14 providing a promising example of TGFb antagonists in cancer therapy. [15] [16] [17] On the other hand, BMP4 can induce astrocytic differentiation of primary human GICs, thus depleting their tumorigenicity and acting therapeutically. 18 Along the same lines, a group of primary human GICs misexpresses the Polycomb regulator, EZH2, which silences epigenetically one of the BMP type I receptors, causing enhanced tumorigenicity as BMP-induced differentiation is bypassed. 19 The molecular repertoire controlled by BMP signaling in GICs remains elusive.
In this study, we screened for BMP-regulated genes in GBM and focussed on the transcription factor Snail. Snail is a pro-invasive factor in carcinomas and promotes breast cancer stem cell survival. 20 Consistently, we show that Snail is required for GBM cell migration and invasion, as tested by wound healing and xenograft assays, respectively. However, Snail decreases gliomasphere formation and suppresses tumor formation, suggesting a dual function of Snail in GBM that dissociates invasiveness from tumorigenic potential.
RESULTS

Characterization of human GBM cell models
GICs are found in some GBM cell lines derived from human patients. 21 To investigate human GIC responses to TGFb and BMP, we analyzed in vitro growth and gliomasphere formation in the established cell lines (U-2987 MG, U-2990 MG, U-343 MG and U-343 MGa-Cl2.6) 22 and in newly isolated patient-derived stem cell lines (U-3028 MG and U-3034 MG) explanted from glioblastomas. We found that U-2987/3028/3034 MG cells readily formed gliomaspheres, whereas the other cell lines formed unordered aggregates (U-2990/343 MG-a-Cl2.6) or sparse adherent cells (U-343 MG; Figure 1a ). mRNA analysis of established GIC markers showed that U-2987/ 3028/3034 MG cells expressed significantly high levels of the cell surface marker CD133, the transcription factor Sox2 and the intermediate filament protein Nestin, whereas the other cell lines expressed undetectable or variable levels of the markers (Figures  1b and c) . Nestin and CD133 protein expression was confirmed in U-2987 MG primary gliomaspheres (Figure 1d ).
The self-renewal capacity of U-2987 MG cells was verified after dissociation of primary gliomaspheres and low-density replating in stem cell media, forming secondary gliomaspheres (Figure 1e ). Immunostaining for GFAP and bIII tubulin confirmed the expression of both glial and neuronal markers, respectively, which verified multipotency (Figure 1f) . Thus, U-2987 MG cells fulfilled the expected features of GICs in vitro, and were used to identify new downstream targets of TGFb and BMP.
Loss of U-2987 MG GIC potential by BMP7 TGFb1 promotes GIC maintenance and tumorigenic potential, whereas BMP4 induces GIC differentiation and loss of tumorigenicity. [10] [11] [12] 18 We used BMP7 instead of BMP4, as BMP7 and its receptors have been involved in GBM development. 23 Analysis of Smad1 and Smad2 C-terminal phosphorylation showed that TGFb1 induced P-Smad2, but not P-Smad1. As a negative control, the TGFb type I receptor kinase inhibitor, GW6604, 24 blocked basal and TGFb1-inducible P-Smad2 (Figure 2a , left panel). BMP7 induced P-Smad1; unexpectedly, GW6604 weakly blocked this response (Figure 2a , right panels), whereas BMP7 also induced P-Smad2, albeit much weaker than TGFb1, and the latter was fully blocked by GW6604 (Figure 2a TGFb-like ligands that activate P-Smad2 or, alternatively, BMP7 may signal via heteromeric type I receptors that activate both Smad1 and Smad2.
Primary and secondary gliomasphere assays showed that TGFb1 induced, whereas GW6604 or BMP7 suppressed the growth of gliomaspheres (Figure 2b ). The effects of GW6604 on P-Smad2 levels and gliomaspheres suggested that autocrine TGFb helped in gliomasphere formation (Figures 2a and b) . The positive effect that TGFb1 had on gliomasphere formation could not result from increased cell proliferation, as these tumor cells, as expected, did not exhibit any robust growth responses to TGFb1 treatment (Supplementary Figure S1a) . Quantification of primary and secondary gliomaspheres confirmed the positive effect of TGFb1 and the inhibitory effect of the GW6604 inhibitor (Supplementary Figure S1b) . Stem-cell marker analysis showed that TGFb1 induced LIF and the stem cell transcription factor Nanog, and downregulated the transcription factors Olig1 and Olig2 (Supplementary Figure S1c ). Upon BMP7 treatment, cells acquired an adherent phenotype ( Figure 2b ) and expressed high levels of GFAP, a marker of astrocytic differentiation (Figure 2c ). To better understand the effects of TGFb1 and BMP7 on U-2987 MG gliomasphere formation, we measured Nestin expression, which was weakly downregulated at the mRNA and more potently at the protein level by BMP7 (Figures 2c and d) . We also confirmed that long-term stimulation with BMP7 induced GFAP and downregulated Olig1 and Olig2 mRNAs (Figure 2d ). Olig1/2 are basic helix-loop-helix transcription factors expressed in neural progenitor cells (NPCs) that promote oligodendrocyte differentiation and potentiate GBM initiation in xenograft experiments. [25] [26] [27] [28] We conclude that in U-2987 MG cells, TGFb1 and BMP7 produce phenotypes similar to those recently established in independent GICs. BMP7 signals via Smads to induce Snail expression in glioblastoma cells In order to find new regulators involved in GIC responses to BMP7, we analyzed BMP7-regulated genes using Affymetrix transcriptomic profiling in U-2987 MG cells (data not shown). Human NPCs were also analyzed in order to compare GICs to normal stem cells. The details of the transcriptomic profiles will be published elsewhere.
Among the BMP7-regulated genes that showed early (2 h) and sustained (24 h) response in both U-2987 MG and human NPCs was the transcription factor Snail that is an established regulator of epithelial-mesenchymal transition. 29 Quantitative (q) RT-PCR and immunoblot analysis confirmed that BMP7 induced Snail mRNA and protein in U-2987 MG cells (Figure 2e ). Furthermore, BMP7 induced Snail in several independent GBM lines (Figure 3a) , which was verified in additional patient-derived GBMs (U-3028/ 3034 MG), albeit with different kinetic profiles in each cell line (Figures 3a and b) . Snail upregulation correlated with GFAP upregulation and Olig1/2 downregulation, whereas a weak but significant downregulation of Nestin was measured in U-3028 MG cells ( Figure 3b Orthotopic injection of mock clones in the brain of immunocompromised mice generated tumors ( Figure 6 ). Mock clones injected either as adherent cells or after dissociation from gliomaspheres led to similar tumor growth (Table 1) . However, tumors generated from gliomaspheres were more invasive, independent of the expression level of Snail. Previous studies suggested that Snail favors cell survival. 31, 32 Despite that, Snailtransfected cells induced tumor formation in 40% of the injected mice compared with 94% of the mice induced by mock clones (Table 1 ). In addition, mice bearing Snail-overexpressing tumors survived longer and lacked signs of illness compared with mice bearing control tumors, which developed illness and were sacrificed earlier (Po0.001; Table 1 ).
Brain histochemical analysis showed that invasive Snail-overexpressing GBM cells were distinguishable from host cells by the high levels of activated, phosphorylated Akt kinase (Supplementary Figure S5 ). Mock-and Snail-overexpressing GBMs formed invasive tumors, however, Snail-overexpressing GBMs had a more scattered pattern, migrating deeper into the brain, whereas mock-GBMs invaded as cell sheets, showing less spreading into the host tissue (Figures 6a-d) . To facilitate the identification of Snail-expressing tumor cells within the mouse brain, we co-transfected GFP and again observed that Snail-expressing tumor cells spread in a patterned manner from the site of injection towards the brain center (Figures 6e-j) . In contrast, GFPtagged mock clones generated large tumor masses with less cell scattering (Figures 6e, g and i) . Finally, whereas mock-transfected GBMs had a heterogeneous differentiation profile, expressing astrocytic GFAP, neuronal bIII tubulin and mesenchymal fibronectin ( Figure 7 , left panels), Snail-expressing GBMs completely lacked expression of the neuronal marker bIII tubulin ( Figure 7 , right panels). These results suggest that Snail promotes astrocytic differentiation, leading to less heterogeneous and smaller tumors while increasing tumor scattering within the brain.
Snail promotes cell migration and suppresses gliomasphere formation To better understand the effects of Snail in vivo, we analyzed tumor cell migration and gliomasphere formation in vitro. Whereas Snail induces cell migration of carcinoma cells, 20 its effect on GBM cell migration is unclear. Scratch assays with Snail-knockdown clones compared with control clones (shCT) showed significant reduction in wound closure (Supplementary Figure S6) , which reflected the degree of Snail knockdown (stronger in shSnail no. 1 and weaker in shSnail no. 2) (Figure 5c ). Thus, under in vitro culture conditions, Snail promoted GBM cell migration. Furthermore, stimulation with BMP7 enhanced shCT cell migration, however, no significant effect by BMP7 was seen after Snail knockdown (Supplementary Figure  S6) . Importantly, the effect of BMP7 on migration did not result from increased cell proliferation (Supplementary Figure S1a) .
Prior to gliomasphere assays, we analyzed GFAP and Nestin levels by comparing side-by-side cells with low Snail (mock clones A and B) to cells with high Snail (Snail clones F and G) (Figures 8a-c) . High Snail expression positively correlated with high GFAP levels. Immunostaining also revealed a strong increase in GFAP-positive cell numbers in the presence of high Snail without effects on Nestin expression (Figure 8c ). Moreover, Snail overexpression resulted in reduced Olig1/2 expression (Supplementary Figure S7) . Strikingly, Snail-transfected cells failed to form gliomaspheres compared with mock cells (Figure 8d ). Snail-transfected cells became adherent and resembled parental BMP7-stimulated cells (Figure 2b ). Therefore, in vitro, Snail impairs the potential of GBM cells to form gliomaspheres in a manner similar to BMP7. Snail overexpression only partially phenocopied the BMP7 response of GBM cells, as BMP7 downregulated Nestin expression (Figure 2c ), but Snail did not (Figure 8c ).
DISCUSSION
Autocrine TGFb favors growth, invasiveness and angiogenesis of GBM. 17 Blocking TGFb signaling is therefore advantageous as a complementary treatment for GBM, and phase I/II clinical trials Snail function in glioblastoma K Savary et al evaluate this clinical approach. 15 Mechanistically, TGFb induces GBM tumor growth via Smad-mediated transcriptional induction of Sox4, platelet-derived growth factor-B and LIF, the latter two cytokines supporting GIC survival and tumor expansion. [10] [11] [12] Consistently, we found that TGFb increased the ability of GICs to self-renew in low-density assays and induced the expression of genes involved in self-renewal, such as LIF and Nanog (Figure 2,  Supplementary Figure S1 ). On the other hand, BMP members suppress GBM tumorigenesis possibly by driving GICs towards astrocytic differentiation, 18 suggesting that BMP ligands could also act therapeutically. Consistently, we found that BMP7 impaired gliomasphere formation and enhanced GFAP expression ( Figures  2 and 3) .
By interrogating the roles of BMP in modulating the in vitro stem-like cell characteristics of human GBM cells, we identified the transcription factor Snail as a new molecular factor downstream of (Figures 2 and 3 ). BMP7 induced Snail expression via Smad1, Smad5 and Smad4, independently of the TGFb receptor-activated Smads, Smad2 and Smad3, even though BMP7 could promote Smad2 C-terminal phosphorylation ( Figures  2 and 4) . Moreover, Snail was required for BMP7-induced GFAP expression (Figure 5b ). Snail expression has been reported in some GBMs, 33, 34 whereas its contribution to GBM tumorigenicity remains unknown. Snail expression in glioblastoma cells promoted migration in vitro and enhanced tumor cell scattering within the recipient brain in vivo ( Figure 6 , Supplementary Figure  S6) , which is reminiscent of its role in neural crest migration during embryonic development, 35 and consistent with the effect of Snail2/Slug, a closely related transcription factor, in inducing glioblastoma cell migration and invasiveness. 36 In vitro, Snail was required for both basal and BMP7-induced migratory capacity (Supplementary Figure S6) . This finding deserves deeper investigation in order to explain the molecular circuit that is driven by Snail to promote GBM invasiveness.
Moreover, Snail-overexpressing cells in vivo showed limited pluripotency, as they expressed stronger astrocytic and mesenchymal markers, whereas lacking neuronal marker expression (Figure 7 ). Along the same lines, BMP4 can induce astrocytic differentiation and potent migration of the normal neural stem cells. 37 Although Snail-overexpressing cells showed high phosphoAkt levels during brain invasion (Supplementary Figure S5) , which might confer a survival advantage to the tumor, we reproducibly found that Snail minimized the extent of tumorigenicity ( Figure 6 , Table 1 ). We cannot fully exclude the possibility that Snailexpressing cells within the mouse brain might have a different late-onset impact on GBM outgrowth, if allowed to remain beyond 12 weeks. However, the antitumorigenic effect of Snail is compatible with the established tumor-suppressor actions of BMPs in GBM 18 and the suppression of gliomasphere formation by Snail (Figure 8 ). In agreement with this model, GBMs that showed relative resistance to BMP-induced gliomasphere suppression also failed to induce Snail (Supplementary Figure S2) . Thus, one way by which BMPs may counteract GBM tumorigenicity is by Snail induction. It has also been described that suppression of GBM tumorigenesis by BMP7 requires downregulation of transcription factor Olig2. 25 In agreement, we have found that BMP7 downregulated Olig1/2 expression, an effect also seen in Snailoverexpressing cells (Figures 2 and 3, Supplementary Figure S7 ). It would be interesting to analyze whether repression of Olig1/2 is required for the invasive activity of Snail.
Snail induction correlated with GFAP upregulation and GIC differentiation (Figures 2, 3, 5-8 ). Both Snail and BMP7 induced GFAP, however, only BMP7 but not Snail, downregulated Nestin (Figures 2, 3, 8) . It is therefore interesting to define the subset of BMP responses in GBM cells that depend on the direct activity of Snail. A transcriptomic screen that we have performed aims at addressing this question in the context of GICs. GFAP expression is known to be controlled by cytokines such as LIF and also by BMPs via a mechanism that depends on crosstalk between Stat3 and Smad1. 38, 39 As Snail is an established transcriptional repressor, 29 it is likely that Snail indirectly regulates GFAP expression, possibly by repressing other neuroectodermal genes, which directly regulate GFAP transcription. This notion is supported by our observation that Snail was unable to regulate a 2 kbp promoter fragment of the GFAP gene (data not shown). The GFAP promoter contains E-box sequences whose functional importance remains unknown. Snail function in glioblastoma K Savary et al Thus, our work opens the exciting possibility that comparative analysis of invasive properties of glioblastomas and carcinomas may provide new clues into tumor cell behavior. It is likely that Snail is a central factor in these processes independent from the specific cell type of origin that the tumor evolved from. This work represents one of the few examples where the interlinked capacity of GBMs to grow and invade is dissociated. Moreover, it supports the notion that both invasiveness and tumorigenicity need to be targeted by new therapies against brain cancer.
MATERIALS AND METHODS
Cell culture, cytokines, antibodies and plasmids
The new human glioblastoma stem cell lines, U-3013/3024/3028/3034 MG, were established as follows: human GBM grade IV biopsies were obtained in accordance with the protocol approved by the Uppsala ethical review board (2007/353), and were graded by neuropathologist Irina Alafuzoff, Uppsala University Hospital, according to the World Health Organization guidelines. Tumor biopsies were minced (1 mm Â 1 mm bits) and digested by 1:1 ratio of Accutase (eBioscience, San Diego, CA, USA)/TrypLE (Invitrogen, Life Technologies Europe BV, Stockholm, Sweden), at 37 1C for 15 min and triturated through 18 and 21 g needles five times. Dissociated cells were resuspended in DMEM/F12 Glutamax (GIBCO, Life Technologies Europe BV, Stockholm, Sweden) and Neurobasal medium (GIBCO) mixed in 1:1 ratio, with the addition of 1% B27 (Invitrogen, Life Technologies Europe BV), 0.5% N2 (Invitrogen, Life Technologies Europe BV), 1% penicillin/streptomycin (Sigma-Aldrich Sweden AB, Stockholm, Sweden), 10 ng/ml EGF and FGF2 (PeproTech, EC Ltd, London, UK), and plated at 100 000 cells/ml. After primary sphere formation, spheres were seeded onto poly-ornithine/laminin-coated dishes and cultured as adherent cells as described. 41 U-3013/3024/3028/3034 MG cells were used at passages 15-30. GBM cells U-343 MG, U-343 MGa-Cl2:6, U-2990 MG and U-2987 MG were previously described, 22 and were maintained in MEM, 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Primary human NPCs were obtained from Lonza Ltd, Basel, Switzerland (NHNP, PT-2599/5F0029) and were cultured per manufacturer's instructions. Human hepatocarcinoma HepG2 cells were cultured in DMEM, 10% FBS, 100 U/ml penicillin and 100 mg/ml streptomycin, as described. 42 Glioblastoma cells in regular or stem cell media were treated with TGFb1, BMP7 or with the inhibitors GW6604, SB505124 and DMH1 (dorsomorphin homolog 1) after 8-24 h starvation in a medium without serum or in the continuous presence of stem cell medium. DMSO served as a vehicle. Recombinant human TGFb1 was from (PeproTech, EC Ltd.) or from Biosource International, Inc (Camarillo, CA, USA), and recombinant human BMP7 was a gift from K. Sampath (Curis, Inc., Boston, MA, USA).
The antibodies used are: rabbit anti-Nestin, (Chemicon International Inc., Temecula, CA, USA), rabbit anti-GFAP (Dako Sweden AB, Stockholm, Sweden), goat anti-Snail, mouse anti-b tubulin and mouse anti-GAPDH (Santa Cruz Biotechnologies Inc., Heidelberg, Germany), mouse anti-bIII tubulin (Abcam, Cambridge, UK), mouse anti-CD133 (Myltenyi Biotec Norden AB, Lund, Sweden), rabbit anti-P-Smad2 (home-made, Uppsala, Sweden), rabbit anti-P-Smad1, rabbit anti-Smad1, rabbit anti-pAkt (Cell Signaling Technology Inc., Danvers, MA, USA) and rabbit anti-Fibronectin (Sigma).
Human Flag-tagged Smad1, Smad4 and Smad5 were expressed under the control of pcDNA3, as described. 42 The human Snail promoter luciferase plasmid was provided by A García-Herreros (IMIM, Barcelona, Spain). 30 Cell growth, proliferation and migration assays Cells growing in regular media were counted in a Beckman Coulter (Beckman Coulter AB, Bromma, Sweden) counter after each passage (every 3-4 days) over a 2-week period. Growth was measured by MTS assay (CellTiter-96 Aqueous-One-Solution Assay, Promega Biotech AB, Stockholm, Sweden). Proliferation in stem cell media was determined by measuring nuclear 5 0 -ethynyl-2 0 -deoxyuridine (EdU) incorporation. Briefly, cells seeded over poly-lysine/laminine-coated chamber slides (Beckton Dickinson AB, Stockholm, Sweden) for 24 h to allow for adhesion, were fed EdU for 1.5 h and EdU-positive cells were recorded using the Click-iT EdU Alexa Fluor 488 Imaging Kit (Invitrogen).
Wound healing assays were performed by scratching confluent cell monolayers, followed by immediate stimulation with BMP7 (30 ng/ml) in the presence of 3% FBS; wound size was monitored 48 h later.
Gliomasphere and differentiation analysis Primary gliomaspheres were formed by plating 80 000 GBM cells per well in stem cell medium: MEM, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, 25 ng/ml EGF, 25 ng/ml bFGF and B27 complement (Invitrogen). Medium was refreshed every 2-3 days, and gliomasphere numbers and size were recorded; gliomaspheres were then collected for RNA or protein extraction, or adhered onto poly-L-lysine/ laminin-coated slides and maintained undifferentiated in stem cell medium for 6 days before immunostaining.
GBM self-renewal capacity was assessed by dissociating primary gliomaspheres and plating the cells at low/clonogenic density (1000 cells 
Transfections and RNAi
The empty vectors pcDNA3 and pSuperior-Neo-GFP (pSGN/shControl), and the vector containing Snail cDNA (pcDNA3-Snail) or the small hairpin RNA against Snail (shSnail) were previously described; 43, 44 they were transfected into U-2987 MG cells using the calcium phosphate coprecipitation method (pcDNA3 and pcDNA3-Snail) or Fugene-HD (Promega Biotech AB) (pSGN and shSnail), and clones were obtained after selection with antibiotics. Stable clones expressing pcDNA3 and pcDNA3-Snail were transfected with pcDNA3-GFP using Fugene-HD, and GFP-positive cells were sorted by FACS, 1 week after selection with antibiotics. Transient transfection of HepG2 cells with the Snail luciferase reporter and Smad expression vectors was performed using the calcium phosphate coprecipitation method, as described. 44 ON-TARGETplus SMARTpool siRNA specific for human Snail, Smad1, Smad2, Smad3, Smad4, Smad5, non-target siRNA control and transfection reagents were from Dharmacon Thermo Fischer Scientific, Lafayette, CO, USA.
Histology, immunostaining and immunobloting
For immunocytochemistry, gliomaspheres or adherent cells were washed twice with PBS containing Ca 2 þ and Mg 2 þ , and either fixed in 3% paraformaldehyde and permeabilized with 0.3% Triton X-100, or fixed in ice-cold methanol. The slides were blocked in 3% goat serum and 0.5% glycine, incubated with primary antibody, briefly washed three times, incubated in the dark with the secondary antibody either conjugated to Alexa-543 or Alexa-488 and stained with either DAPI or propidium iodide to visualize the nuclei before mounting in fluoromount (SouthernBiotech, Birmingham, AL, USA).
Imaging was performed under a fluorescent microscope (Leica Microsystems AB, Kista, Sweden) or a Zeiss Axiovert 200 M confocal microscope equipped with LSM 510 laser with a 63 Â /0.75 objective lens and photographing at ambient temperature in the presence of immersion oil, with a Hamamatsu C4742-95 CCD digital camera and software QED Camera Plugin v1.1.6 (QED Imaging Inc., Pittsburgh, PA, USA) and Volocity (PerkinElmer Inc., Waltham, MA, USA). Phase contrast images were obtained either with a Zeiss confocal microscope or with an inverted Zeiss AxioVision microscope and AxioCam camera. Histological analysis was done using a Leica Qwin Series microscope with a Leica DFC camera. Image file size was reduced with Adobe Photoshop CS2. Immunoblot analysis of GBM protein extracts using the antibodies listed above was performed as described. 45 Real-time qRT-PCR analysis Total cellular RNA was purified with the RNeasy kit (Qiagen AB, Sollentuna, Sweden) and cDNA was synthesized from 0.5 mg of RNA using the iQ kit (Bio-Rad Laboratories AB, Solna, Sweden). qRT-PCR conditions were as described 45 Promoter reporter assays
The human Snail promoter was co-transfected with reporter plasmid pCMV-bGal for normalization, and expression vectors pcDNA3 (control), Flag-Smad1, Flag-Smad5 and/or Flag-Smad4 in HepG2 cells. Cells were stimulated with 30 ng/ml BMP7 for 24 h. The enhanced luciferase assay kit from BD Pharmingen (Beckton Dickinson AB, Stockholm, Sweden) was used. Normalized promoter activity data are plotted in bar graphs representing mean ± s.d. from triplicate samples. Each independent experiment was repeated at least twice.
Statistical analysis
Statistical analysis was done using excel and P values o0.05 were considered significant. qRT-PCR, wound healing and mouse survival data were tested for statistical significance using the two-sided Student's t-test. The Fisher's exact test was applied for comparing the incidence of tumor formation in mouse xenograft experiments. All quantitative data are presented as mean±s.d. estimated from triplicate or more determinations per experiment.
